Overview

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Status:
Unknown status

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

This study aims to assess if Lucentis injection applied into the eye is superior to conventional treatment concerning the prevention of visual loss in patients having clinically significant macular edema secondary to retinal vein occlusion

Phase:

Phase 2

Details

Lead Sponsor:

University of Pecs

Collaborator:

University of Debrecen

Treatments:

Ranibizumab